P3 Health Partners (NASDAQ:PIII – Get Free Report) and InnovAge (NASDAQ:INNV – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability.
Risk and Volatility
P3 Health Partners has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, InnovAge has a beta of 0.09, suggesting that its stock price is 91% less volatile than the S&P 500.
This is a summary of current ratings and recommmendations for P3 Health Partners and InnovAge, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|P3 Health Partners||0||1||1||0||2.50|
Valuation & Earnings
This table compares P3 Health Partners and InnovAge’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|P3 Health Partners||$1.05 billion||0.40||-$270.13 million||($2,260.66)||0.00|
|InnovAge||$688.09 million||1.10||-$40.67 million||($0.29)||-19.14|
InnovAge has lower revenue, but higher earnings than P3 Health Partners. InnovAge is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
23.6% of P3 Health Partners shares are owned by institutional investors. Comparatively, 12.2% of InnovAge shares are owned by institutional investors. 17.1% of P3 Health Partners shares are owned by insiders. Comparatively, 0.4% of InnovAge shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
This table compares P3 Health Partners and InnovAge’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|P3 Health Partners||-10.73%||2,454.69%||37.99%|
P3 Health Partners beats InnovAge on 9 of the 13 factors compared between the two stocks.
About P3 Health Partners
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.